Royal Bank of Canada’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-17,123
| Closed | -$57K | – | 7275 |
|
|
2019
Q4 | $57K | Buy |
17,123
+1,309
| +8% | +$4.16K | ﹤0.01% | 5393 |
|
|
2019
Q3 | $48K | Buy |
15,814
+2,120
| +15% | +$5.96K | ﹤0.01% | 5142 |
|
|
2019
Q2 | $33K | Buy |
13,694
+6,037
| +79% | +$18K | ﹤0.01% | 5477 |
|
|
2019
Q1 | $29K | Sell |
7,657
-4,311
| -36% | -$16.2K | ﹤0.01% | 5477 |
|
|
2018
Q4 | $43K | Buy |
11,968
+6,068
| +103% | +$26.4K | ﹤0.01% | 5183 |
|
|
2018
Q3 | $34K | Buy |
5,900
+2,480
| +73% | +$14.2K | ﹤0.01% | 5422 |
|
|
2018
Q2 | $17K | Sell |
3,420
-2,584
| -43% | -$13.3K | ﹤0.01% | 5622 |
|
|
2018
Q1 | $31K | Buy |
6,004
+6,001
| +200,033% | +$36.1K | ﹤0.01% | 5283 |
|
|
2017
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 7130 |
|
|
2017
Q3 | $0 | Buy |
+3
| New | +$15 | ﹤0.01% | 7153 |
|
|
2016
Q1 | – | Sell |
-73
| Closed | -$1K | – | 6818 |
|
|
2015
Q4 | $1K | Sell |
73
-1,029
| -93% | -$7.69K | ﹤0.01% | 6539 |
|
|
2015
Q3 | $8K | Sell |
1,102
-521
| -32% | -$5.31K | ﹤0.01% | 6009 |
|
|
2015
Q2 | $17K | Buy |
+1,623
| New | +$17.9K | ﹤0.01% | 5795 |
|
Royal Bank of Canada's FOMX Position: Q1 2020 in Review
Royal Bank of Canada sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 17,123 shares — an estimated $57K sold.
Royal Bank of Canada first reported a position in FOMX in Q2 2015 and held it in 13 quarters. The position peaked at $57K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.
- Royal Bank of Canada reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
- Royal Bank of Canada sold 17,123 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $57K.
- Royal Bank of Canada first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 13 quarters.
- Royal Bank of Canada's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $57K in Q4 2019.
- 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.
Based on Royal Bank of Canada's 13F filing for Q1 2020, filed 15 May 2020.